NeurAxis, Inc. (NRXS) Revenue History
Annual and quarterly revenue from 2020 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NRXS Revenue Growth
Revenue Breakdown
NRXS's revenue distribution by segment and geography
By Geography
NRXS Revenue Analysis (2020–2025)
As of May 8, 2026, NeurAxis, Inc. (NRXS) generated trailing twelve-month (TTM) revenue of $3.6 million, reflecting exceptional growth of +27.2% year-over-year. The most recent quarter (Q4 2025) recorded $968,127 in revenue, up 19.3% sequentially.
Looking at the longer-term picture, NRXS's 5-year compound annual growth rate (CAGR) stands at +13.1%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $3.6 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including LIVN (+12.4% YoY), ELMD (+15.5% YoY), and STIM (+69.5% YoY), NRXS has underperformed the peer group in terms of revenue growth. Compare NRXS vs LIVN →
NRXS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NRXSCurrent | $4M | +27.2% | +13.1% | -219.4% | |
 LIVN | $1.4B | +12.4% | +8.2% | 14.4% | |
 ELMD | $64M | +15.5% | +14.5% | 15.1% | |
 STIM | $149M | +69.5% | +24.8% | -21.1% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% |
NRXS Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $3.6M | +32.9% | $3.0M | 84.2% | $-7,829,908 | -219.4% |
| 2024 | $2.7M | +9.2% | $2.3M | 86.5% | $-7,156,817 | -266.5% |
| 2023 | $2.5M | -8.4% | $2.2M | 87.7% | $-6,664,495 | -270.9% |
| 2022 | $2.7M | -1.3% | $2.4M | 88.9% | $-3,372,238 | -125.6% |
| 2021 | $2.7M | +41.0% | $2.3M | 82.8% | $-2,970,034 | -109.1% |
| 2020 | $1.9M | - | $1.4M | 75.1% | $-4,120,738 | -213.5% |
See NRXS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NRXS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NRXS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNRXS — Frequently Asked Questions
Quick answers to the most common questions about buying NRXS stock.
Is NRXS's revenue growth accelerating or slowing?
NRXS revenue is accelerating at +27.2% year-over-year, exceeding the 5-year CAGR of +13.1%. TTM revenue reached $4M. Growth momentum has increased versus prior periods.
What is NRXS's long-term revenue growth rate?
NeurAxis, Inc.'s 5-year revenue CAGR of +13.1% reflects the sustained expansion pattern. Current YoY growth of +27.2% is above this long-term average.
How is NRXS's revenue distributed by segment?
NRXS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2025 are available for download. Segment mix reveals concentration and diversification trends.